Medicare Enrolled
Dr. Ali Achira, M.D
Endocrinology · Dearborn, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Achira from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Achira?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Achira
Dr. Ali Achira is an endocrinology specialist in Dearborn, MI, with 15 years of NPI registration. Based on federal Medicare data, Dr. Achira performed 1,791 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Achira received a total of $8,566 from 55 pharmaceutical and/or device companies across 567 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Achira is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years of NPI registration
▲ Top 23% volume in MI
$8,566 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,791
Medicare services
Top 23% in MI for endocrinology
Not available
Unique patients (not deduplicated)
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
496 | $84 | $112 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
361 | $60 | $76 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
300 | $3 | $10 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
121 | $28 | $37 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
110 | $53 | $77 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
98 | $126 | $171 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
82 | $106 | $144 |
| Continuous glucose monitoring, sensor under skin This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin with provider-supplied equipment. |
59 | $113 | $153 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
41 | $33 | $41 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
33 | $26 | $43 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
32 | $138 | $212 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
30 | $89 | $117 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
16 | $77 | $113 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
12 | $106 | $151 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$8,566
Total received (2018-2024)
Avg $1,224/year across 7 years
Top 27% in MI for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
567
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,372
2023
$1,725
2022
$1,696
2021
$1,757
2020
$539
2019
$321
2018
$1,156
Payments by company (2024)
Lilly USA, LLC
$247
Novo Nordisk Inc
$237
BETA BIONICS, INC.
$112
Dexcom, Inc.
$84
Corcept Therapeutics
$74
Tandem Diabetes Care, Inc.
$73
Amgen Inc.
$68
RECORDATI_RARE_DISEASES_INC.
$54
Mannkind Corporation
$52
Boehringer Ingelheim Pharmaceuticals, Inc.
$52
Amneal Pharmaceuticals LLC
$40
VIVUS LLC
$34
CeQur Corporation
$32
Medtronic, Inc.
$30
Abbott Laboratories
$29
ABBVIE INC.
$24
Neurocrine Biosciences, Inc.
$21
TheracosBio, LLC
$21
Alvogen Inc
$19
Xeris Pharmaceuticals, Inc.
$16
Verity Pharmaceuticals Inc.
$15
Insulet Corporation
$14
SANOFI-AVENTIS U.S. LLC
$13
Acella Pharmaceuticals, LLC
$13
Top 3 companies account for 43.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,645
Lilly USA, LLC
$977
Currax Pharmaceuticals LLC
$646
Dexcom, Inc.
$594
AstraZeneca Pharmaceuticals LP
$514
Amgen Inc.
$364
Boehringer Ingelheim Pharmaceuticals, Inc.
$307
Corcept Therapeutics
$245
SANOFI-AVENTIS U.S. LLC
$216
Amneal Pharmaceuticals LLC
$184
Xeris Pharmaceuticals, Inc.
$180
Nevro Corp.
$177
Abbott Laboratories
$177
CeQur Corporation
$158
Radius Health, Inc.
$142
DEXCOM, INC.
$136
Tandem Diabetes Care, Inc.
$135
Rhythm Pharmaceuticals, Inc.
$131
AbbVie, Inc.
$122
BETA BIONICS, INC.
$112
Medtronic, Inc.
$101
Insulet Corporation
$97
Bayer HealthCare Pharmaceuticals Inc.
$91
RECORDATI_RARE_DISEASES_INC.
$82
Mannkind Corporation
$79
Ultragenyx Pharmaceutical Inc.
$76
Janssen Pharmaceuticals, Inc
$70
Orexigen Therapeutics, Inc.
$68
AbbVie Inc.
$63
VIVUS LLC
$61
Bayer Healthcare Pharmaceuticals Inc.
$52
MannKind Corporation
$43
Embecta Corp.
$40
Antares Pharma, Inc.
$39
Medtronic MiniMed, Inc.
$37
Ipsen Biopharmaceuticals, Inc
$32
Regeneron Healthcare Solutions, Inc.
$31
Eisai Inc.
$30
Merck Sharp & Dohme Corporation
$27
ABBVIE INC.
$24
Supernus Pharmaceuticals, Inc.
$22
Zealand Pharma US, Inc.
$22
GlaxoSmithKline, LLC.
$22
Neurocrine Biosciences, Inc.
$21
TheracosBio, LLC
$21
Endo Pharmaceuticals Inc.
$20
Ascendis Pharma Inc
$19
Alvogen Inc
$19
LifeScan, Inc.
$18
Horizon Therapeutics plc
$15
Verity Pharmaceuticals Inc.
$15
Astellas Pharma US Inc
$14
Acella Pharmaceuticals, LLC
$13
Amarin Pharma Inc.
$12
Novartis Pharmaceuticals Corporation
$12
Top 3 companies account for 38.2% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BAQSIMI · BD Nano 2nd Gen Pen Needle · Belviq · Brenzavvy · CONTRAVE · CREON · CeQur Simplicity · Crysvita · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EVENITY · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMULIN · HUMULIN R 500 · ILARIS · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · Imcivree · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · MINIMED 770G · MINIMED 780G · MOUNJARO · Macrilen · Minimed 670G System · NASCOBAL · NEXLETOL · NOCDURNA · NP Thyroid 60 · NovoLog · Omnipod · OneTouch Verio Reflect · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · QSYMIA · Qsymia · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SYNTHROID · Saxenda · Senza · Somatuline Depot · TEPEZZA · TERIPARATIDE · TLANDO · TOUJEO · TRELEGY ELLIPTA · TRULICITY · TZIELD · Tlando · Tymlos · UNITHROID · V-GO DISPOSABLE INSULIN DELIVERY · Vascepa · Veozah · Victoza · Wegovy · ZEPBOUND · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
87
County median income
$59,521
Nearest hospital to ZIP centroid (approximate)
BEAUMONT HOSPITAL - DEARBORN
3.8 mi
3.8 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Achira is a clinical cardiology specialist, with above-average Medicare volume (top 23% in MI), with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Achira experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Achira performed 496 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Achira receive payments from pharmaceutical companies?
Yes. Dr. Achira received a total of $8,566 from 55 companies across 567 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Achira's costs compare to other endocrinologists in Dearborn?
Dr. Achira's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Achira) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Dearborn
Browse endocrinologists in Dearborn ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in MI
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in MI
Which MI endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Currax Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Currax Pharmaceuticals LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology